Abstract
The prostate cancer is the second most common among men in Brazil (approximately 28% of cases) and in recent years there was an increase in incidence, with high mortality rate. Guidelines established by the Brazilian Society of Urology (SBU) recommend that the diagnosis should be predicted after performing rectal (DRE) and prostate-specific antigen (PSA). The definitive diagnosis is made …